Sirius Investors

Vertex Pharmaceuticals Incorporated (VRTX) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate Vertex Pharmaceuticals Incorporated's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Investment Score:
40/100
Fair

Valuation Metrics

P/E Ratio
-193.61
Weak
WeakModerateStrong
P/B Ratio
6.32
Strong
WeakModerateStrong
Earnings Yield
-0.52%
Weak
WeakModerateStrong

Profitability Health

Return on Equity
-3.26%
Weak
WeakModerateStrong
Operating Margin
-2.11%
Weak
WeakModerateStrong
Net Profit Margin
-4.86%
Weak
WeakModerateStrong

Growth Indicators

Revenue Growth
11.66%
Strong
WeakModerateStrong
Net Income Growth
-114.80%
Weak
WeakModerateStrong
EPS Growth
-114.80%
Weak
WeakModerateStrong

Efficiency & Liquidity

Current Ratio
2.69
Strong
WeakModerateStrong
Quick Ratio
2.35
Strong
WeakModerateStrong
Asset Turnover
0.49x
Weak
WeakModerateStrong
Inventory Turnover
1.27x
Weak
WeakModerateStrong